Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnostics, R&D, Prognostics), Region - Global Forecast to 2026
... to reach USD 28.2billion by 2026 from USD 12.4billion in 2021, at a CAGR of 17.7% during the forecast period. Market growth is driven by factors such as therising technological advancements In the development of ... Read More
-
Global Chronic Eosinophilic Leukemia Market - 2022-2029
... a CAGR of XX% during the forecast period (2022-2029). Chronic eosinophilic leukemia is a subtype of clonal eosinophilia caused by a new genetic mutation or change in blood cells. It is also known as a ... Read More
-
Global Cryotherapy Market Size study, By Product (Cryosurgery Devices, Localized Cryotherapy Devices, Cryochambers & Cryosaunas), By Application (Surgical Applications, Pain Management, Recovery, Health, and Beauty), By End User (Hospitals & Specialty Clinics, Cryotherapy Centers, Spas & Fitness Centers), and Regional Forecasts 2022-2028
... & Fitness Centers), and Regional Forecasts 2022-2028 Global Cryotherapy Market is valued approximately USD 224.75 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.1% over the forecast ... Read More
-
Blood Cancer Drugs Global Market Report 2022
... blood cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Thyroid Cancer Drugs Global Market Report 2022
... thyroid cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Kidney Cancer Drugs Global Market Report 2022
... kidney cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Ovarian Cancer Drugs Global Market Report 2022
... ovarian cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Colorectal Cancer Drugs Global Market Report 2022
... colorectal cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Gastric Cancer Drugs Global Market Report 2022
... gastric cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
North America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The North America monoclonal antibodies market is expected to grow from US$ 54,629.4 million in 2021 to US$ ... Read More
-
Europe Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Europe monoclonal antibodies market is expected to reach US$ 61,019.8 million by 2028 from US$ 29,254.3 million in ... Read More
-
Cervical Cancer Drugs Global Market Report 2022
... cervical cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Prostate Cancer Drugs Global Market Report 2022
... prostate cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Bladder Cancer Drugs Global Market Report 2022
... bladder cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecast to 2026
... is projected to reach USD 647 million by 2026 from USD 567 million in 2021, at a CAGR of 2.7%. Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, ... Read More
-
2022 Global Forecast for Patient Derived Xenograft (Pdx) Models (2023-2028 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material ... Read More
-
2022 Global Forecast for Particle Therapy (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Oncology Nutrition (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Middle East and Africa Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in MEA ... Read More
-
Asia Pacific Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in APAC is expected ... Read More
-
North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in North America is ... Read More
-
South America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in SAM is expected ... Read More
-
Europe Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in Europe is expected to ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... ganglioside GD2 is a major focus of drug developers. There are 131 drugs in the pipeline with 98% molecules present in early-to-mid stage. Mid-sized Pharma dominates clinical development in this space. More frequent use of ... Read More
Research Assistance
